ERBB2 and neoplasm: Among the concordant samples, dMMR/MSI-H status was associated with an early tumor stage (P = 0.050), intestinal type of Lauren classification (P = 0.058), lower HER2 expression (P = 0.034), and EBV negativity (P = 0.008, Additional file 1: Table S5).